JP2003012516A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003012516A5 JP2003012516A5 JP2001391481A JP2001391481A JP2003012516A5 JP 2003012516 A5 JP2003012516 A5 JP 2003012516A5 JP 2001391481 A JP2001391481 A JP 2001391481A JP 2001391481 A JP2001391481 A JP 2001391481A JP 2003012516 A5 JP2003012516 A5 JP 2003012516A5
- Authority
- JP
- Japan
- Prior art keywords
- calmodulin
- calcium
- kinase inhibitor
- dependent kinase
- hydrogen atom
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001391481A JP4153693B2 (en) | 2001-04-25 | 2001-12-25 | Novel CaMKK inhibitor |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001127524 | 2001-04-25 | ||
JP2001-127524 | 2001-04-25 | ||
JP2001391481A JP4153693B2 (en) | 2001-04-25 | 2001-12-25 | Novel CaMKK inhibitor |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2003012516A JP2003012516A (en) | 2003-01-15 |
JP2003012516A5 true JP2003012516A5 (en) | 2005-07-14 |
JP4153693B2 JP4153693B2 (en) | 2008-09-24 |
Family
ID=26614177
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2001391481A Expired - Fee Related JP4153693B2 (en) | 2001-04-25 | 2001-12-25 | Novel CaMKK inhibitor |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP4153693B2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8207185B2 (en) | 2006-10-12 | 2012-06-26 | Duke University | CaMKKβ as a target for treating obesity |
US20130253035A1 (en) | 2010-08-16 | 2013-09-26 | Duke University | Camkk-beta as a target for treating cancer |
US9790423B2 (en) * | 2013-08-05 | 2017-10-17 | Basf Se | Cyanated naphthalenebenzimidazole compounds |
SG11202101522WA (en) * | 2018-08-20 | 2021-03-30 | Univ Duke | Methods and compositions for drugs to treat ophthalmic diseases |
-
2001
- 2001-12-25 JP JP2001391481A patent/JP4153693B2/en not_active Expired - Fee Related
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0302693A2 (en) | Phenylalanin-derivatives, integrin inhibitors of alpha4, their use and process for their preparation | |
JP2004516314A5 (en) | ||
CA2379560A1 (en) | Purine derivatives inhibitors of tyrosine protein kinase syk | |
JP2010501478A5 (en) | ||
GEP20074033B (en) | Benzofused heteroaryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use | |
HUP0104666A2 (en) | Thyroid receptor ligands | |
EP1797878A3 (en) | Benzothiazole derivatives | |
BR0311541A (en) | indole, azaindole and 4-akenyl piperidine related heterocyclic amides | |
PL367618A1 (en) | 5-halo-tryptamine derivatives used as ligands of the 5-ht6 and/or 5-ht 7 serotonin receptors | |
JP2002525323A5 (en) | ||
JP2003503449A5 (en) | ||
WO2001064645A3 (en) | Derivatives of quinoline as alpha-2 antagonists | |
AP2002002664A0 (en) | Cyclohexylamine derivative as subtype selective NMDA receptor antagonists. | |
HUP0100865A2 (en) | Meta-azacyclic amino benzoic acid compounds and derivatives thereof being integrin antagonists, pharmaceutical compositions comprising thereof and their use | |
NO20040881L (en) | Oral antidiabetic agents. | |
RU2002100058A (en) | 1-Methylcarbapenem Crystal Derivatives | |
JP2000159790A5 (en) | ||
PT992509E (en) | NEW MACROLIDED DERIVATIVES | |
JP2002506864A5 (en) | ||
RS20060239A (en) | Arylalkylcarbamate derivatives, preparation method thereof and use of same in therapeutics | |
JP2003012516A5 (en) | ||
CA2300289A1 (en) | A pharmaceutical composition active in reducing production of mcp-1 protein | |
ZA200704584B (en) | New 3-Phenylpropionic acid derivatives for the treatment of diabetes | |
JP2008519001A5 (en) | ||
CA2088702A1 (en) | Aminobenzoic acid derivatives |